About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00057616

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Su...

Lead sponsor: Celgene•49 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Celgene

Collaborators

ICON Clinical Research

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Understand and voluntarily sign an informed consent form
•Able to adhere to the study visit schedule and other protocol requirements
•Metastatic malignant melanoma now stage IV, relapsed or refractory to standard metastatic therapy
•Women of childbearing potential must have a negative serum or urine pregnancy test within 7 days of starting study drug
•Patients with active brain disease, or newly diagnosed brain metastases, within 4 weeks prior to the start of study treatment are excluded.

Related studies

RECRUITINGPhase 2

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

NCT06594991 · Advanced Melanoma

RECRUITINGPhase 1

A Study of BI 3810944 in Patients With Advanced Cancer

NCT07224425 · Solid Tumours, Melanoma

RECRUITINGPhase 2

A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

NCT02621021 · Melanoma

Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in Melanoma

NCT07564570 · Metastatic Melanoma

RECRUITINGPhase 3

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

NCT06500455 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment274

Start dateOct 2002

Last updatedNov 8, 2019

Condition

Melanoma Neoplasm Metastasis

Locations shown

The Canberra Hospital

Garran, Australian Capital Territory

Royal Prince Alfred Hospital

Camperdown, New South Wales

Sydney Cancer Centre

Camperdown, New South Wales

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2019Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions